Literature DB >> 12236201

Proposed diagnostic criteria and nosology of acute transverse myelitis.

.   

Abstract

Acute transverse myelitis (ATM) is a focal inflammatory disorder of the spinal cord, resulting in motor, sensory, and autonomic dysfunction. A set of uniform diagnostic criteria and nosology for ATM is proposed to avoid the confusion that inevitably results when investigators use differing criteria. This will ensure a common language of classification, reduce diagnostic confusion, and lay the groundwork necessary for multicenter clinical trials. In addition, a framework is suggested for evaluation of individuals presenting with signs and symptoms of ATM. Best treatment often depends on a timely and accurate diagnosis. Because acute transverse myelopathies are relatively rare, delayed and incomplete work-ups often occur. Rapid and precise diagnosis will ensure not only that compressive lesions are detected and treated but also that idiopathic ATM is distinguished from ATM secondary to a known underlying disease. Identification of etiologies may suggest medical treatment, whereas no clearly established medical treatment currently exists for idiopathic ATM. Establishment of a diagnostic algorithm will likely lead to improved care, although it is recognized that the entire evaluation may not be performed for each patient.

Entities:  

Mesh:

Year:  2002        PMID: 12236201     DOI: 10.1212/wnl.59.4.499

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  169 in total

1.  Spinal cord ischemia: aetiology, clinical syndromes and imaging features.

Authors:  Stefan Weidauer; Michael Nichtweiß; Elke Hattingen; Joachim Berkefeld
Journal:  Neuroradiology       Date:  2014-11-16       Impact factor: 2.804

Review 2.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

3.  Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?

Authors:  Viviana Nociti; Anna Paola Batocchi; Marco Luigetti; Amelia Conte; Vita Santa Lorusso; Silvia Roiati; Tommaso Tartaglione; Alessandra Del Grande; Mario Sabatelli
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

4.  MR imaging findings in delayed reversible myelopathy from lightning strike.

Authors:  Cynthia B Freeman; Mayank Goyal; Pierre R Bourque
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

5.  Neurological complications of biologic therapy in psoriasis: a review.

Authors:  Mark Bechtel; Catherine Sanders; Ann Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

Review 6.  Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria.

Authors:  Mahmoud A AbdelRazek; Ashkan Mowla; Salman Farooq; Nicholas Silvestri; Robert Sawyer; Gil Wolfe
Journal:  J Spinal Cord Med       Date:  2015-12-17       Impact factor: 1.985

7.  Neurological symptoms simulating cord compression in breast cancer patient.

Authors:  Antonio Sanchez; Constanza Maximiano; Blanca Cantos; Enric Carcereny; Pilar España
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

8.  Analysis of 30 Spinal Angiograms Falsely Reported as Normal in 18 Patients with Subsequently Documented Spinal Vascular Malformations.

Authors:  P Barreras; D Heck; B Greenberg; J-P Wolinsky; C A Pardo; P Gailloud
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

9.  The incidence of clinically isolated syndrome in a multi-ethnic cohort.

Authors:  Annette Langer-Gould; Sonu M Brara; Brandon E Beaber; Jian L Zhang
Journal:  J Neurol       Date:  2014-04-29       Impact factor: 4.849

10.  Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.

Authors:  Katharina Wolf; Thomas Schmitt-Mechelke; Spyridon Kollias; Armin Curt
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.